choline has been researched along with Adenocarcinoma in 74 studies
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 62-year-old patient with prostate adenocarcinoma underwent PET with radiolabeled choline (18F-Fcholine) for pretreatment staging of a high-risk prostate cancer." | 7.81 | Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer. ( De Clermont, H; Fernandez, P; Parrens, M; Pasticier, G; Pinaquy, JB, 2015) |
| "We report the results of whole body 18F-fluorocholine (FCH) PET/CT in a single patient with biochemical suspicion of prostate adenocarcinoma relapse and recent history of minor head injury." | 7.80 | Intense 18F-choline uptake after minor head injury: misleading PET/CT result in a patient with biochemical relapse of prostate adenocarcinoma. ( Imperiale, A; Leyendecker, P; Matern, JF; Namer, IJ; Noël, G, 2014) |
| "Choline metabolism and proliferation as assessed by PET were correlated in ER-positive breast cancer, indicating that high CHO uptake is a measure of cellular proliferation in this setting." | 7.77 | Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography. ( Aboagye, EO; Al-Nahhas, A; Challapalli, A; Contractor, KB; Coombes, RC; De Nguyen, Q; Hogben, K; Kenny, LM; Lewis, JS; Palmieri, C; Shousha, S; Stebbing, J, 2011) |
| "Choline is an essential nutrient for cell survival and proliferation, however, the expression and function of choline transporters have not been well identified in cancer." | 5.34 | Choline transporters in human lung adenocarcinoma: expression and functional implications. ( Chen, F; Gu, J; He, X; Li, J; Wan, D; Wang, T; Zhao, Y, 2007) |
| "A 62-year-old patient with prostate adenocarcinoma underwent PET with radiolabeled choline (18F-Fcholine) for pretreatment staging of a high-risk prostate cancer." | 3.81 | Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer. ( De Clermont, H; Fernandez, P; Parrens, M; Pasticier, G; Pinaquy, JB, 2015) |
| "A 65-year-old patient with prostate adenocarcinoma was explored by 18F-fluorocholine (FCH) PET/CT for pretreatment staging because of a high risk of prostate cancer." | 3.81 | Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT. ( Allard, JB; Cornelis, F; De Clermont, H; Pasticier, G; Pinaquy, JB, 2015) |
| "We report the results of whole body 18F-fluorocholine (FCH) PET/CT in a single patient with biochemical suspicion of prostate adenocarcinoma relapse and recent history of minor head injury." | 3.80 | Intense 18F-choline uptake after minor head injury: misleading PET/CT result in a patient with biochemical relapse of prostate adenocarcinoma. ( Imperiale, A; Leyendecker, P; Matern, JF; Namer, IJ; Noël, G, 2014) |
| "Choline metabolism and proliferation as assessed by PET were correlated in ER-positive breast cancer, indicating that high CHO uptake is a measure of cellular proliferation in this setting." | 3.77 | Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography. ( Aboagye, EO; Al-Nahhas, A; Challapalli, A; Contractor, KB; Coombes, RC; De Nguyen, Q; Hogben, K; Kenny, LM; Lewis, JS; Palmieri, C; Shousha, S; Stebbing, J, 2011) |
| "The aim of this study was to assess the accuracy and clinical impact of [(11)C]choline PET/CT for localizing occult relapse of prostate adenocarcinoma after radical prostatectomy." | 3.74 | [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy. ( Blumstein, NM; Glatting, G; Reske, SN, 2008) |
| "By comparing the intensity of resonances assigned to choline, creatine, lipid, and lysine, MR spectroscopy can depict prostate carcinoma with a high degree of sensitivity and specificity." | 3.72 | Pathologic characterization of human prostate tissue with proton MR spectroscopy. ( Himmelreich, U; Khadra, M; Lean, C; McCredie, S; Mountford, C; Russell, P; Swindle, P, 2003) |
| "The ether lipid analogue 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3) has been shown to be a direct inhibitor of Swiss 3T3 fibroblast and BG1 ovarian adenocarcinoma cell cytosolic phosphoinositide selective phospholipase C (PIPLC) using [3H]-phosphatidylinositol-(4, 5)-bisphosphate ([3H]PIP2) as the substrate." | 3.68 | Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. ( Gratas, C; Melder, D; Modest, EJ; Powis, G; Riebow, J; Seewald, MJ, 1992) |
| "Lung cancers were analysed visually and semiquantitatively using the ratio of tumour-to-normal radioactivity (T/N ratio) and standardized uptake value (SUV)." | 2.71 | A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer. ( Endo, K; Higuchi, T; Inoue, T; Khan, N; Oriuchi, N; Sato, N; Tian, M; Zhang, H, 2003) |
| "For the diagnosis of recurrent ovarian cancer (n = 3), (11)C-choline PET and (18)F-FDG PET were true-positive in 1 patient, whereas neither tracer could detect cystic recurrent tumor and microscopic peritoneal disease in the other 2 patients." | 2.71 | Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. ( Futatsubashi, M; Kanno, T; Maeda, M; Nakamura, F; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E, 2003) |
| "The management of prostate cancer has dramatically changed over the last decades, mainly due to improvement of diagnostic modalities and development of new therapeutic strategies." | 2.66 | Prostate imaging: Contribution of PET PSMA and MRI. ( Abecassis, JP; Ghazzar, N; Giraud, P; Peyromaure, M, 2020) |
| "The role of PET imaging in prostate cancer is gradually evolving but still remains within the experimental realm." | 2.44 | Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse? ( Cascini, GL; Greco, C; Tamburrini, O, 2008) |
| "multi-parametric MRI in the prostate cancer relapse." | 1.42 | (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer. ( Cozar, M; Escobar, M; Garcia, JR; Moragas, M; Romera, N; Soler, M, 2015) |
| "Primary therapies for prostate cancer were 19 radical prostatectomy, 18 radiotherapy, 13 radiotherapy with hormonal treatment, 3 brachytherapy." | 1.42 | [Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence]. ( Arnoux, V; Boillot, B; Carnicelli, D; Descotes, JL; Dubreuil, J; Fiard, G; Lanchon, C; Long, JA; Poncet, D; Rambeaud, JJ; Terrier, N; Verry, C, 2015) |
| "Nine patients with prostate cancer were scanned with an endorectal coil (ERC) on a 7-T MR scanner." | 1.40 | Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe. ( Arteaga de Castro, CS; Bhogal, A; Boer, VO; Klomp, DW; Luijten, PR; Luttje, MP; van der Heide, UA; van der Velden, TA; van Vulpen, M, 2014) |
| "To diagnose rectal cancer and monitor treatment response after preoperative concurrent chemoradiotherapy (CCRT) in rectal cancer patients using proton-1 magnetic resonance spectroscopy ((1)H-MRS)." | 1.38 | Detection of rectal cancer and response to concurrent chemoradiotherapy by proton magnetic resonance spectroscopy. ( Chun, HK; Kim, MJ; Kim, SH; Lee, JH; Lee, SJ; Lim, HK; Yun, SH, 2012) |
| "Choline is an essential nutrient that serves as a donor of metabolic methyl groups used during gestation to establish the epigenetic DNA methylation patterns that modulate tissue-specific gene expression." | 1.35 | Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival. ( Blusztajn, JK; Davison, JM; Kovacheva, VP; Mellott, TJ; O'Brien, MJ; Rogers, AE; Yang, S, 2009) |
| "Although prostate cancer in TRAMP mice shares some metabolic features with that in humans, it differs with respect to choline phospholipid metabolism, which could impact upon the interpretation of results from biomarker or chemotherapy/chemoprevention studies." | 1.35 | Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism. ( Edwards, RE; Farmer, PB; Gant, TW; Gescher, AJ; Greaves, P; Jones, DJ; Keun, HC; Steward, WP; Teahan, O; Teichert, F; Verschoyle, RD; Wilson, ID, 2008) |
| "Choline is an essential nutrient for cell survival and proliferation, however, the expression and function of choline transporters have not been well identified in cancer." | 1.34 | Choline transporters in human lung adenocarcinoma: expression and functional implications. ( Chen, F; Gu, J; He, X; Li, J; Wan, D; Wang, T; Zhao, Y, 2007) |
| "Prostate cancer is known for its difficulties in preoperative staging of pelvic lymph nodes by conventional imaging techniques." | 1.32 | Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. ( de Jong, IJ; Elsinga, PH; Mensink, HJ; Pruim, J; Vaalburg, W, 2003) |
| "In specimens (Borrmann type III) with tubular adenocarcinoma, resonance peaks were observed at 1." | 1.32 | Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma. ( Cha, SS; Cho, JY; Choi, KS; Eun, CK; Kim, J; Lee, J; Lee, SY; Mun, CW; Nam, SH; Shin, WJ; Yang, YI, 2004) |
| "The exact staging of prostate cancer is mandatory to allow selection of the appropriate primary therapy." | 1.31 | [The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging]. ( Ackermann, R; Coenen, HH; Hautzel, H; Herzog, H; Krause, BJ; Müller-Gärtner, HW; Müller-Mattheis, V; Roden, W, 2002) |
| "PET was performed on 10 prostate cancer patients from the level of pelvis to the lower abdomen." | 1.30 | PET imaging of prostate cancer using carbon-11-choline. ( Hara, T; Kishi, H; Kosaka, N, 1998) |
| "An estimate of the spatial extent of prostate cancer was determined by generating metabolite images in which this metabolite ratio significantly exceeded normal peripheral zone values in multiple contiguous sections." | 1.29 | Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. ( Carroll, P; Hricak, H; Kurhanewicz, J; Narayan, P; Nelson, SJ; Vigneron, DB, 1996) |
| "Choline was not effective in inhibiting the development of lung metastases in either case." | 1.27 | Effect of methionine and choline on liver tumor promotion by phenobarbital and DDT in diethylnitrosamine-initiated rats. ( Hoover, KL; Poirier, LA; Shivapurkar, N, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (8.11) | 18.7374 |
| 1990's | 10 (13.51) | 18.2507 |
| 2000's | 23 (31.08) | 29.6817 |
| 2010's | 30 (40.54) | 24.3611 |
| 2020's | 5 (6.76) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, C | 3 |
| Liu, D | 3 |
| Wang, F | 3 |
| Liu, Y | 3 |
| Xie, J | 6 |
| Xie, Y | 3 |
| Fuentes-Baile, M | 1 |
| Bello-Gil, D | 1 |
| Pérez-Valenciano, E | 1 |
| Sanz, JM | 1 |
| García-Morales, P | 1 |
| Maestro, B | 1 |
| Ventero, MP | 1 |
| Alenda, C | 1 |
| Barberá, VM | 1 |
| Saceda, M | 1 |
| Turpin, L | 1 |
| Pouliot, Q | 1 |
| Zhang, J | 1 |
| Glikman, M | 1 |
| Gomez, F | 1 |
| Talbot, JN | 1 |
| Montravers, F | 1 |
| Abecassis, JP | 1 |
| Ghazzar, N | 1 |
| Peyromaure, M | 1 |
| Giraud, P | 1 |
| Latge, A | 1 |
| Heimburger, C | 1 |
| Severac, F | 1 |
| Meyer, N | 1 |
| Somme, F | 1 |
| Imperiale, A | 3 |
| Conteduca, V | 1 |
| Scarpi, E | 1 |
| Caroli, P | 1 |
| Salvi, S | 1 |
| Lolli, C | 1 |
| Burgio, SL | 1 |
| Menna, C | 1 |
| Schepisi, G | 1 |
| Testoni, S | 1 |
| Gurioli, G | 1 |
| Paganelli, G | 1 |
| Casadio, V | 1 |
| Matteucci, F | 1 |
| De Giorgi, U | 1 |
| Dejust, S | 1 |
| Messaoud, L | 1 |
| Jallerat, P | 1 |
| Marical, V | 1 |
| Morland, D | 1 |
| Mujukian, A | 1 |
| Kay, M | 1 |
| Babu, MA | 1 |
| Spinner, RJ | 1 |
| Dyck, PJ | 1 |
| Amrami, KK | 1 |
| Nathan, MA | 1 |
| Kawashima, A | 1 |
| Howe, BM | 1 |
| Bergerat, JP | 1 |
| Saussine, C | 1 |
| Abu Eid, M | 1 |
| Kehrli, P | 1 |
| Namer, IJ | 2 |
| Chang, JH | 1 |
| Lim Joon, D | 1 |
| Lee, ST | 1 |
| Hiew, CY | 1 |
| Esler, S | 1 |
| Gong, SJ | 1 |
| Wada, M | 1 |
| Clouston, D | 1 |
| O'Sullivan, R | 1 |
| Goh, YP | 1 |
| Tochon-Danguy, H | 1 |
| Chan, JG | 1 |
| Bolton, D | 1 |
| Scott, AM | 1 |
| Khoo, V | 1 |
| Davis, ID | 1 |
| Leyendecker, P | 1 |
| Matern, JF | 1 |
| Noël, G | 1 |
| Cochet, A | 1 |
| Kanoun, S | 1 |
| Humbert, O | 1 |
| Walker, PM | 1 |
| Cormier, L | 1 |
| Créhange, G | 1 |
| Brunotte, F | 1 |
| Arteaga de Castro, CS | 1 |
| Boer, VO | 1 |
| Luttje, MP | 1 |
| van der Velden, TA | 1 |
| Bhogal, A | 1 |
| van Vulpen, M | 1 |
| Luijten, PR | 1 |
| van der Heide, UA | 1 |
| Klomp, DW | 2 |
| Trousil, S | 1 |
| Lee, P | 1 |
| Pinato, DJ | 1 |
| Ellis, JK | 1 |
| Dina, R | 2 |
| Aboagye, EO | 2 |
| Keun, HC | 3 |
| Sharma, R | 1 |
| Garcia, JR | 2 |
| Romera, N | 1 |
| Cozar, M | 1 |
| Soler, M | 2 |
| Moragas, M | 1 |
| Escobar, M | 1 |
| Tabrizipour, AI | 1 |
| Dunne, M | 1 |
| Pinaquy, JB | 2 |
| Fernandez, P | 1 |
| Pasticier, G | 2 |
| Parrens, M | 1 |
| De Clermont, H | 2 |
| Allard, JB | 1 |
| Cornelis, F | 1 |
| Giovacchini, G | 1 |
| Incerti, E | 1 |
| Mapelli, P | 1 |
| Kirienko, M | 1 |
| Briganti, A | 1 |
| Gandaglia, G | 1 |
| Montorsi, F | 1 |
| Gianolli, L | 2 |
| Picchio, M | 2 |
| Matrone, F | 1 |
| Sivolella, S | 1 |
| Bellavita, R | 1 |
| Casciola, L | 1 |
| Cristallini, EG | 1 |
| Aristei, C | 1 |
| Poncet, D | 1 |
| Arnoux, V | 1 |
| Descotes, JL | 1 |
| Rambeaud, JJ | 1 |
| Verry, C | 1 |
| Terrier, N | 1 |
| Boillot, B | 1 |
| Dubreuil, J | 1 |
| Lanchon, C | 1 |
| Carnicelli, D | 1 |
| Fiard, G | 1 |
| Long, JA | 1 |
| Piert, M | 1 |
| Montgomery, J | 1 |
| Kunju, LP | 1 |
| Siddiqui, J | 1 |
| Rogers, V | 1 |
| Rajendiran, T | 1 |
| Johnson, TD | 1 |
| Shao, X | 1 |
| Davenport, MS | 1 |
| Jacob, M | 1 |
| Delfort, F | 1 |
| Heliette, C | 1 |
| Renard, D | 1 |
| Scalzi, P | 1 |
| Baiocco, C | 1 |
| Genovese, S | 1 |
| Trevisan, A | 1 |
| Sirotova, Z | 1 |
| Poti, C | 1 |
| Calabrese, C | 1 |
| Pisi, A | 1 |
| Di Febo, G | 1 |
| Liguori, G | 1 |
| Filippini, G | 1 |
| Cervellera, M | 1 |
| Righi, V | 1 |
| Lucchi, P | 1 |
| Mucci, A | 1 |
| Schenetti, L | 1 |
| Tonini, V | 1 |
| Tosi, MR | 1 |
| Tugnoli, V | 1 |
| Mansilla, F | 1 |
| da Costa, KA | 1 |
| Wang, S | 1 |
| Kruhøffer, M | 1 |
| Lewin, TM | 1 |
| Orntoft, TF | 1 |
| Coleman, RA | 1 |
| Birkenkamp-Demtröder, K | 1 |
| Kovacheva, VP | 1 |
| Davison, JM | 1 |
| Mellott, TJ | 1 |
| Rogers, AE | 1 |
| Yang, S | 1 |
| O'Brien, MJ | 1 |
| Blusztajn, JK | 1 |
| Galván-Portillo, MV | 1 |
| Cantoral, A | 1 |
| Oñate-Ocaña, LF | 1 |
| Chen, J | 1 |
| Herrera-Goepfert, R | 1 |
| Torres-Sanchez, L | 1 |
| Hernandez-Ramirez, RU | 1 |
| Palma-Coca, O | 1 |
| López-Carrillo, L | 1 |
| Raina, K | 1 |
| Serkova, NJ | 1 |
| Agarwal, R | 1 |
| Watanabe, H | 1 |
| Kanematsu, M | 1 |
| Kondo, H | 1 |
| Kako, N | 1 |
| Yamamoto, N | 1 |
| Yamada, T | 1 |
| Goshima, S | 1 |
| Hoshi, H | 1 |
| Bae, KT | 1 |
| Al-Saffar, NM | 1 |
| Jackson, LE | 1 |
| Raynaud, FI | 1 |
| Clarke, PA | 1 |
| Ramírez de Molina, A | 1 |
| Lacal, JC | 1 |
| Workman, P | 1 |
| Leach, MO | 1 |
| García-Martín, ML | 1 |
| Adrados, M | 1 |
| Ortega, MP | 1 |
| Fernández González, I | 1 |
| López-Larrubia, P | 1 |
| Viaño, J | 1 |
| García-Segura, JM | 1 |
| Budiharto, T | 1 |
| Joniau, S | 1 |
| Lerut, E | 1 |
| Van den Bergh, L | 1 |
| Mottaghy, F | 1 |
| Deroose, CM | 1 |
| Oyen, R | 1 |
| Ameye, F | 1 |
| Bogaerts, K | 1 |
| Haustermans, K | 1 |
| Van Poppel, H | 1 |
| Contractor, KB | 1 |
| Kenny, LM | 1 |
| Stebbing, J | 1 |
| Challapalli, A | 1 |
| Al-Nahhas, A | 1 |
| Palmieri, C | 1 |
| Shousha, S | 1 |
| Lewis, JS | 1 |
| Hogben, K | 1 |
| De Nguyen, Q | 1 |
| Coombes, RC | 1 |
| Evans-Axelsson, S | 1 |
| Ulmert, D | 1 |
| Örbom, A | 1 |
| Peterson, P | 1 |
| Nilsson, O | 1 |
| Wennerberg, J | 1 |
| Strand, J | 1 |
| Wingårdh, K | 1 |
| Olsson, T | 1 |
| Hagman, Z | 1 |
| Tolmachev, V | 1 |
| Bjartell, A | 1 |
| Lilja, H | 1 |
| Strand, SE | 1 |
| Kim, MJ | 1 |
| Lee, SJ | 1 |
| Lee, JH | 2 |
| Kim, SH | 2 |
| Chun, HK | 1 |
| Lim, HK | 1 |
| Yun, SH | 1 |
| Aguilo, JJ | 1 |
| Marco, V | 1 |
| Valls, E | 1 |
| Lomeña, F | 1 |
| Li, M | 1 |
| Peng, Z | 1 |
| Liu, Q | 2 |
| Sun, J | 1 |
| Yao, S | 1 |
| Jiménez, B | 1 |
| Mirnezami, R | 1 |
| Kinross, J | 1 |
| Cloarec, O | 1 |
| Holmes, E | 1 |
| Goldin, RD | 1 |
| Ziprin, P | 1 |
| Darzi, A | 1 |
| Nicholson, JK | 1 |
| Landoni, C | 1 |
| Messa, C | 1 |
| Matarrese, M | 1 |
| De Cobelli, F | 1 |
| Maschio, AD | 1 |
| Fazio, F | 1 |
| Hautzel, H | 1 |
| Müller-Mattheis, V | 1 |
| Herzog, H | 1 |
| Roden, W | 1 |
| Coenen, HH | 1 |
| Ackermann, R | 1 |
| Müller-Gärtner, HW | 1 |
| Krause, BJ | 1 |
| de Jong, IJ | 1 |
| Pruim, J | 1 |
| Elsinga, PH | 1 |
| Vaalburg, W | 1 |
| Mensink, HJ | 1 |
| Khan, N | 1 |
| Oriuchi, N | 1 |
| Zhang, H | 1 |
| Higuchi, T | 1 |
| Tian, M | 1 |
| Inoue, T | 1 |
| Sato, N | 1 |
| Endo, K | 2 |
| Swindle, P | 1 |
| McCredie, S | 1 |
| Russell, P | 1 |
| Himmelreich, U | 1 |
| Khadra, M | 1 |
| Lean, C | 1 |
| Mountford, C | 1 |
| Torizuka, T | 1 |
| Kanno, T | 1 |
| Futatsubashi, M | 1 |
| Okada, H | 1 |
| Yoshikawa, E | 1 |
| Nakamura, F | 1 |
| Takekuma, M | 1 |
| Maeda, M | 1 |
| Ouchi, Y | 1 |
| Mahon, MM | 1 |
| Cox, IJ | 1 |
| Soutter, WP | 1 |
| McIndoe, GA | 1 |
| Williams, AD | 1 |
| deSouza, NM | 1 |
| Mun, CW | 2 |
| Cho, JY | 1 |
| Shin, WJ | 1 |
| Choi, KS | 1 |
| Eun, CK | 1 |
| Cha, SS | 1 |
| Lee, J | 1 |
| Yang, YI | 1 |
| Nam, SH | 1 |
| Kim, J | 1 |
| Lee, SY | 1 |
| Guo, J | 1 |
| Higashi, K | 1 |
| Yokota, H | 1 |
| Nagao, Y | 1 |
| Ueda, Y | 1 |
| Kodama, Y | 1 |
| Oguchi, M | 1 |
| Taki, S | 1 |
| Tonami, H | 1 |
| Yamamoto, I | 1 |
| Taouli, B | 1 |
| Maeda, T | 2 |
| Tateishi, U | 2 |
| Komiyama, M | 1 |
| Fujimoto, H | 1 |
| Watanabe, S | 1 |
| Terauchi, T | 2 |
| Moriyama, N | 2 |
| Arai, Y | 1 |
| Sugimura, K | 1 |
| Kakizoe, T | 2 |
| Heijmink, SW | 1 |
| Scheenen, TW | 1 |
| Fütterer, JJ | 1 |
| Heesakkers, RA | 1 |
| Hulsbergen-van de Kaa, CA | 1 |
| van Lin, EN | 1 |
| Heerschap, A | 1 |
| Barentsz, JO | 1 |
| Wang, T | 1 |
| Li, J | 1 |
| Chen, F | 1 |
| Zhao, Y | 1 |
| He, X | 1 |
| Wan, D | 1 |
| Gu, J | 1 |
| Reske, SN | 1 |
| Blumstein, NM | 1 |
| Glatting, G | 1 |
| Kanou, D | 1 |
| Daisaki, H | 1 |
| Moriya, Y | 1 |
| Greco, C | 1 |
| Cascini, GL | 1 |
| Tamburrini, O | 1 |
| Teichert, F | 1 |
| Verschoyle, RD | 1 |
| Greaves, P | 1 |
| Edwards, RE | 1 |
| Teahan, O | 1 |
| Jones, DJ | 1 |
| Wilson, ID | 1 |
| Farmer, PB | 1 |
| Steward, WP | 1 |
| Gant, TW | 1 |
| Gescher, AJ | 1 |
| Rémy-Heintz, N | 1 |
| Bali, JP | 1 |
| Sénelar, R | 1 |
| Gastaud, JM | 1 |
| Lean, CL | 1 |
| Newland, RC | 1 |
| Ende, DA | 1 |
| Bokey, EL | 1 |
| Smith, IC | 1 |
| Mountford, CE | 1 |
| Kurhanewicz, J | 1 |
| Vigneron, DB | 1 |
| Hricak, H | 2 |
| Narayan, P | 1 |
| Carroll, P | 1 |
| Nelson, SJ | 1 |
| Nakai, T | 1 |
| Ishima, R | 1 |
| Sakahara, H | 1 |
| Konishi, J | 1 |
| Akasaka, K | 1 |
| Street, JC | 1 |
| Szwergold, BS | 1 |
| Matei, C | 1 |
| Kappler, F | 1 |
| Mahmood, U | 1 |
| Brown, TR | 1 |
| Koutcher, JA | 2 |
| Burtscher, IM | 1 |
| Ståhlberg, F | 1 |
| Holtås, S | 1 |
| Cho, KS | 1 |
| Kim, YM | 1 |
| Kim, ST | 1 |
| Na, JH | 1 |
| Mok, JE | 1 |
| Lim, TH | 1 |
| Hara, T | 1 |
| Kosaka, N | 1 |
| Kishi, H | 1 |
| Zakian, K | 1 |
| Powis, G | 1 |
| Seewald, MJ | 1 |
| Gratas, C | 1 |
| Melder, D | 1 |
| Riebow, J | 1 |
| Modest, EJ | 1 |
| McCormack, SA | 1 |
| Tague, LL | 1 |
| Gragoe, EJ | 1 |
| Johnson, LR | 1 |
| Palmer, KC | 1 |
| Mooradian, DL | 1 |
| Diglio, CA | 1 |
| Shivapurkar, N | 1 |
| Hoover, KL | 1 |
| Poirier, LA | 1 |
| Sahu, AP | 1 |
| Singh, KP | 1 |
| Shukla, LJ | 1 |
| Shanker, R | 1 |
| Khaletskaia, FM | 1 |
| Hillyard, LA | 1 |
| Abraham, S | 1 |
| Hill, DL | 1 |
| Wingo, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Investigation of the Magnitude of Uptake, Retention, and Spatial Distribution Pattern of 18F-Choline in Comparison With MRI and Histology Obtained From Prostate Cancer Biopsies[NCT01751737] | 63 participants (Actual) | Interventional | 2012-11-30 | Completed | |||
| Clinical Value of [18]Fluoroethylcholine Positron-Emission-Tomography Combined With Endorectal Magnetic Resonance Imaging by Software Fusion for Pre-therapeutic Staging of Prostate Cancer[NCT00520546] | Phase 3 | 44 participants (Actual) | Interventional | 2007-12-31 | Completed | ||
| A Multi-center, Open-label, Single Arm Phase III Clinical Trial for the Diagnostic Efficacy Assessment and Safety Evaluation by [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer[NCT05936658] | Phase 3 | 89 participants (Anticipated) | Interventional | 2023-05-08 | Recruiting | ||
| Trans-Rectal Placement of Prostatic Fiducial Markers Under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study[NCT00061347] | Phase 1 | 15 participants (Actual) | Interventional | 2003-05-23 | Completed | ||
| Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma[NCT01377220] | Phase 2 | 30 participants (Anticipated) | Interventional | 2011-06-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
PET positive lesions (n=128) were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative and positive predictive values were determined. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | lesions (Number) | |||||
|---|---|---|---|---|---|---|
| True positive | False positive | True negative | False negative | Total true | Total false | |
| FEC-PET | 59 | 26 | 19 | 24 | 78 | 50 |
| Magnetic Resonance Imaging (MRI) | 40 | 27 | 18 | 43 | 58 | 70 |
| PET/MRI | 55 | 8 | 37 | 28 | 92 | 36 |
PET positive lesions in patients with Gleason >6(3+3),n=43 were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative & positive predictive values were determined. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | lesions (Number) | |||||
|---|---|---|---|---|---|---|
| True positive | False positive | True negative | False negative | Total true | Total false | |
| FEC-PET | 27 | 5 | 8 | 3 | 35 | 8 |
| Magnetic Resonance Imaging (MRI) | 22 | 9 | 4 | 8 | 26 | 17 |
| PET/MRI | 27 | 1 | 11 | 4 | 38 | 5 |
PET positive lesions were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative and positive predictive values were determined without malign lesions <=5mm. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | lesions (Number) | |||||
|---|---|---|---|---|---|---|
| True positive | False positive | True negative | False negative | Total true | Total false | |
| FEC-PET | 48 | 24 | 18 | 8 | 66 | 32 |
| Magnetic Resonance Imaging (MRI) | 37 | 26 | 16 | 19 | 53 | 45 |
| PET/MRI | 48 | 8 | 32 | 10 | 80 | 18 |
PET positive lesions were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. At least 1 histological confirmed cancer lesion has to be detected by each of the 3 methods to be patient based true positive. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | participants (Number) | |||||
|---|---|---|---|---|---|---|
| True Positive | False Positive | True Negative | False Negative | Total True | Total False | |
| [18F]Fluoroethylcholine Positron-Emission-Tomography (FEC-PET) | 36 | 1 | 0 | 1 | 36 | 2 |
| Magnetic Resonance Imaging (MRI) | 26 | 1 | 0 | 11 | 27 | 11 |
| PositronEmissionTomography/MagneticResonanceImaging (PET/MRI) | 35 | 0 | 1 | 2 | 36 | 2 |
5 reviews available for choline and Adenocarcinoma
| Article | Year |
|---|---|
Prostate imaging: Contribution of PET PSMA and MRI.
Topics: Adenocarcinoma; Aged; Antigens, Surface; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Glut | 2020 |
[Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].
Topics: Adenocarcinoma; Brachytherapy; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglu | 2014 |
[MR spectroscopic imaging for evaluation of prostate cancer].
Topics: Adenocarcinoma; Biomarkers; Biopsy; Choline; Citrates; Humans; Magnetic Resonance Imaging; Magnetic | 2006 |
Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?
Topics: Adenocarcinoma; Carbon Radioisotopes; Choline; Clinical Trials as Topic; Humans; Lymphatic Metastasi | 2008 |
Magnetic resonance spectroscopic studies of the prostate.
Topics: Adenocarcinoma; Choline; Citric Acid; Humans; Magnetic Resonance Spectroscopy; Male; Neoplasm Stagin | 2000 |
5 trials available for choline and Adenocarcinoma
| Article | Year |
|---|---|
Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.
Topics: Adenocarcinoma; Aged; Biopsy; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; F | 2014 |
18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Topics: Adenocarcinoma; Aged; Choline; Humans; Image-Guided Biopsy; Magnetic Resonance Imaging; Male; Middle | 2016 |
Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resona | 2010 |
A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Choline | 2003 |
Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Choline | 2003 |
64 other studies available for choline and Adenocarcinoma
| Article | Year |
|---|---|
Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Topics: Adenocarcinoma; Animals; CD8-Positive T-Lymphocytes; Choline; Colonic Neoplasms; Endothelial Cells; | 2022 |
Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Topics: Adenocarcinoma; Animals; CD8-Positive T-Lymphocytes; Choline; Colonic Neoplasms; Endothelial Cells; | 2022 |
Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Topics: Adenocarcinoma; Animals; CD8-Positive T-Lymphocytes; Choline; Colonic Neoplasms; Endothelial Cells; | 2022 |
Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Topics: Adenocarcinoma; Animals; CD8-Positive T-Lymphocytes; Choline; Colonic Neoplasms; Endothelial Cells; | 2022 |
CLytA-DAAO, Free and Immobilized in Magnetic Nanoparticles, induces Cell Death in Human Cancer Cells.
Topics: 3T3-L1 Cells; Adenocarcinoma; Animals; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Survival; | 2020 |
Topics: Adenocarcinoma; Aged; Betacoronavirus; Choline; Convalescence; Coronavirus Infections; COVID-19; Flu | 2020 |
Impact of pelvic dynamic acquisition on final reading of
Topics: Adenocarcinoma; Choline; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Em | 2022 |
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Pr | 2017 |
Hepatic Metastases From Prostatic Adenocarcinoma Without Elevated 18F-Choline Activity.
Topics: Adenocarcinoma; Aged; Biological Transport; Choline; Humans; Liver Neoplasms; Male; Positron Emissio | 2018 |
Indeterminate single bone lesion on multimodality imaging of prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; Diagnosis, Differential; Diphosphonates; Disease Prog | 2019 |
Recurrent prostatic adenocarcinoma with perineural spread to the lumbosacral plexus and sciatic nerve: comparing high resolution MRI with torso and endorectal coils and F-18 FDG and C-11 choline PET/CT.
Topics: Adenocarcinoma; Aged, 80 and over; Biopsy; Choline; Fluorodeoxyglucose F18; Humans; Lumbosacral Plex | 2013 |
Isolated cerebellar metastasis from prostate adenocarcinoma diagnosed by 18F-fluorocholine PET/CT: a rare but not impossible complication.
Topics: Adenocarcinoma; Aged; Cerebellar Neoplasms; Choline; Humans; Male; Multimodal Imaging; Positron-Emis | 2014 |
Intense 18F-choline uptake after minor head injury: misleading PET/CT result in a patient with biochemical relapse of prostate adenocarcinoma.
Topics: Adenocarcinoma; Choline; Diagnostic Errors; Humans; Male; Middle Aged; Multimodal Imaging; Positron- | 2014 |
Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe.
Topics: Adenocarcinoma; Algorithms; Artifacts; Choline; Citrates; Feasibility Studies; Humans; Magnetic Reso | 2014 |
Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway.
Topics: Adenocarcinoma; Cell Line; Cell Line, Tumor; Choline; Choline Kinase; Endometrial Neoplasms; Female; | 2014 |
(11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carbon Radioisotopes; Choline; Combined Modality Therapy; Humans; Ly | 2015 |
The role of 18F-flourocholine PET/CT in biochemically relapsed prostate cancer: a case of osteolytic prostate metastasis.
Topics: Adenocarcinoma; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emi | 2015 |
Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer.
Topics: Adenocarcinoma; Anthracosis; Choline; False Positive Reactions; Humans; Lymphatic Metastasis; Male; | 2015 |
Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT.
Topics: Adenocarcinoma; Aged; Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emis | 2015 |
[¹¹C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Multimodal Imaging; | 2015 |
Use of 18F-choline positron emission tomography/CT in high-risk prostate cancer: a case of solitary adrenal metastasis.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antineoplastic Agents, Hormonal; Bioma | 2015 |
[Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].
Topics: Adenocarcinoma; Aged; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging | 2015 |
Brain 18F-choline PET/CT in primary diffuse leptomeningeal melanomatosis.
Topics: Adenocarcinoma; Choline; Humans; Male; Melanoma; Meningeal Carcinomatosis; Middle Aged; Neoplasms, M | 2016 |
Evaluation of bone metastases by 18F-choline PET/CT in a patient with castration-resistant prostate cancer treated with radium-223.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Positron Emissi | 2017 |
Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy.
Topics: Adenocarcinoma; Aged; Alanine; Biomarkers, Tumor; Choline; Endoscopy, Gastrointestinal; Female; Gast | 2008 |
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Adenocarcinoma; Adult; Aged; Animals; Cell Line, Tumo | 2009 |
Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Carcinogens; Choline; Choline Deficiency; | 2009 |
Gastric cancer in relation to the intake of nutrients involved in one-carbon metabolism among MTHFR 677 TT carriers.
Topics: Adenocarcinoma; Case-Control Studies; Choline; Diet; DNA Methylation; Female; Folic Acid; Genotype; | 2009 |
Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study.
Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Choline; Citrates; Glucose; Inositol; Lipid Metabolism; | 2009 |
The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.
Topics: Adenocarcinoma; Cell Line, Tumor; Choline; Choline Kinase; Down-Regulation; Furans; HCT116 Cells; Hu | 2010 |
Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings.
Topics: Adenocarcinoma; Choline; Citric Acid; Creatine; Humans; In Vitro Techniques; Magnetic Resonance Spec | 2011 |
Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Humans; L | 2011 |
Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Carbon Radioisotopes; Cell Proliferation; Choline; Ch | 2011 |
Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Autoradiography; Choline; Feasibility Studies; Fluo | 2012 |
Detection of rectal cancer and response to concurrent chemoradiotherapy by proton magnetic resonance spectroscopy.
Topics: Adenocarcinoma; Adult; Aged; Chemoradiotherapy; Choline; Female; Humans; Magnetic Resonance Imaging; | 2012 |
Diagnosis of penile metastases of prostatic origin with 11C-Choline PET/CT.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Carbon Radioisotopes; Choline; Combined Modality Th | 2012 |
Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; | 2013 |
1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers, Tumor; Cell Transformation, | 2013 |
Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; False Negative Reactions; Fluorodeoxyglucose F18; Hum | 2002 |
[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
Topics: Acetates; Adenocarcinoma; Amino Acids; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18 | 2002 |
Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Ly | 2003 |
Pathologic characterization of human prostate tissue with proton MR spectroscopy.
Topics: Adenocarcinoma; Biomarkers, Tumor; Choline; Citrates; Creatinine; Diagnosis, Differential; Humans; L | 2003 |
(1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load.
Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chol | 2004 |
Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Topics: Adenocarcinoma; Alanine; Choline; Feasibility Studies; Humans; Lipid Metabolism; Magnetic Resonance | 2004 |
In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Choline; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; | 2004 |
Distant metastasis of prostate cancer: early detection of recurrent tumor with dual-phase carbon-11 choline positron emission tomography/computed tomography in two cases.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Carbon Radioisotopes; Choline; Early Diagnosi | 2006 |
Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy.
Topics: Adenocarcinoma; Aged; Choline; Humans; Image Processing, Computer-Assisted; Lymph Node Excision; Lym | 2007 |
Choline transporters in human lung adenocarcinoma: expression and functional implications.
Topics: Adenocarcinoma; Antigens, CD; Cell Line, Tumor; Choline; Gene Expression Regulation, Neoplastic; Hum | 2007 |
[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.
Topics: Adenocarcinoma; Aged; Biopsy; Carbon Radioisotopes; Choline; Follow-Up Studies; Humans; Male; Middle | 2008 |
A case of colon cancer detected by carbon-11 choline positron emission tomography/computed tomography: an initial report.
Topics: Adenocarcinoma; Biopsy; Carbon Radioisotopes; Choline; Colonic Neoplasms; Female; Humans; Hysterecto | 2007 |
Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.
Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Choline; Choline Kinase; Disease Models, Animal; Gene Ex | 2008 |
[Effect of chlorine-methylated quaternary ammonium on human gastric cancer cell proliferation].
Topics: Adenocarcinoma; Cell Division; Chlorine; Choline; Dose-Response Relationship, Drug; Humans; Membrane | 1993 |
Assessment of human colorectal biopsies by 1H MRS: correlation with histopathology.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amino Acids; Biopsy; Choline; Colorectal Neoplasms; | 1993 |
Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Topics: Adenocarcinoma; Adult; Aged; Choline; Citrates; Citric Acid; Creatine; Diagnosis, Differential; Huma | 1996 |
1H-magnetic resonance spectroscopic observation of cultured malignant cells pharmacologically induced to different phenotypes.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Butyrates; Butyric Acid; Cho | 1996 |
Study of the metabolism of choline and phosphatidylcholine in tumors in vivo using phosphonium-choline.
Topics: Adenocarcinoma; Animals; Choline; Female; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experi | 1997 |
Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neo | 1997 |
Localized in vivo 1H nuclear MR spectroscopy for evaluation of human uterine cervical carcinoma.
Topics: Adenocarcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Choline; Creatine; Female; Human | 1998 |
PET imaging of prostate cancer using carbon-11-choline.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma | 1998 |
PET imaging of prostate cancer using carbon-11-choline.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma | 1998 |
PET imaging of prostate cancer using carbon-11-choline.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma | 1998 |
PET imaging of prostate cancer using carbon-11-choline.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma | 1998 |
Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Cell Division; Choline; Female; Mice; Ovarian Neoplasms; Phospha | 1992 |
Regulation of ornithine decarboxylase activity in LoVo cells.
Topics: Adenocarcinoma; Amiloride; Asparagine; Cell Line; Choline; Colonic Neoplasms; Culture Media; Drug Co | 1990 |
Enhancement of differentiated type 2 cell function in the A549 cell line using mitomycin C1.
Topics: Adenocarcinoma; Cell Differentiation; Cell Division; Cell Line; Choline; Choline-Phosphate Cytidylyl | 1987 |
Effect of methionine and choline on liver tumor promotion by phenobarbital and DDT in diethylnitrosamine-initiated rats.
Topics: Adenocarcinoma; Animals; Choline; Cocarcinogenesis; DDT; Diethylnitrosamine; Liver Neoplasms; Lung N | 1986 |
Choline and mica dust induced pulmonary lesions in rats.
Topics: Adenocarcinoma; Aluminum Silicates; Animals; Choline; Lung; Lung Neoplasms; Male; Pulmonary Fibrosis | 1985 |
[On the pathomorphology of tumors induced by benzocholine 69].
Topics: Adenocarcinoma; Adenoma; Animals; Benzene; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Choline; | 1969 |
Membrane proliferation and phosphatidylcholine synthesis in normal, preneoplastic, and neoplastic mammary gland tissues in C3H mice.
Topics: Adenocarcinoma; Animals; Carbon Isotopes; Choline; Cytochrome c Group; DNA; Endoplasmic Reticulum; F | 1972 |
Nonspecific inhibition of precursor uptake by alkyl-substituted purines and prednisolone.
Topics: Acetates; Adenine; Adenocarcinoma; Animals; Carbon Radioisotopes; Cell Division; Cell Line; Choline; | 1974 |